SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?


To: yosi s who wrote (747)5/4/1999 11:25:00 AM
From: Tony van Werkhooven  Read Replies (1) | Respond to of 1386
 
yosi- it was my recollection that lot/alrex avoided much of the side effects seen with other medications- this was the selling point of the PARS products- could you elaborate on your statement in the prior post?

Anyone have a date for the 1st Q reporting?

Thanks

Tony